Drugs that contain Levomilnacipran Hydrochloride

1. Drug name - FETZIMA

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US8865937 ALLERGAN Crystalline forms of (1S,2R)-2-(amino methyl)-N,N-diethyl-1-phenyl cyclopropane carboxamide
May, 2032

(9 years from now)

These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
USRE43879 ALLERGAN Use of the dextrogyral enantiomer of milnacipran for the preparation of a drug Jan, 2026

(3 years from now)

US8481598 ALLERGAN Stable dosage forms of levomilnacipran Mar, 2031

(8 years from now)

Treatment: Treatment of major depressive disorder (mdd)

Dosage: CAPSULE, EXTENDED RELEASE;ORAL

More Information on Dosage
Strength Dosage Availability
EQ 20MG BASE CAPSULE, EXTENDED RELEASE;ORAL Prescription
EQ 40MG BASE CAPSULE, EXTENDED RELEASE;ORAL Prescription
EQ 80MG BASE CAPSULE, EXTENDED RELEASE;ORAL Prescription
EQ 120MG BASE CAPSULE, EXTENDED RELEASE;ORAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.